{
    "code": "02024563",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024563",
    "time": "2024-04-11 19:38:09",
    "許可證字號": "衛署藥輸字第024563號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/11\/13",
    "發證\/登錄日期": "95\/11\/13",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202456304",
    "中文品名": "益樂鉑定注射液",
    "英文品名": "Eloxatin 5mg\/ml,concentrate for solution for infusion",
    "適應症": "和5-fluorouracil(5-FU)及folinic acid(FA)併用，作為第三期結腸癌(Duke's C)原發腫瘤完全切除手術後的輔助療法。治療轉移性結腸直腸癌。Eloxatin和fluoropyrimidine類藥物併用可用於局部晚期及復發\/轉移性胃癌之治療。與5-fluorouracil、leucovorin及irinotecan合併治療(FOLFIRINOX)，作為轉移性胰臟癌之第一線治療藥物。",
    "劑型": "270注射劑",
    "包裝": "50mg小瓶 100支以下盒裝 100mg小瓶 100支以下盒裝 200mg小瓶 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "OXALIPLATIN",
    "限制項目": "02輸　入",
    "申請商名稱": "賽諾菲股份有限公司",
    "申請商地址": "台北市信義區松仁路3號7樓",
    "主製造廠": [
        {
            "製造廠名稱": "SANOFI-AVENTIS DEUTSCHLAND GMBH",
            "製造廠廠址": "BRUNINGSTRASSE 50, D-65926 FRANKFURT AM MAIN, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "台灣大昌華嘉股份有限公司高上倉",
            "製造廠廠址": "桃園市楊梅區高上路1段150號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "台灣大昌華嘉股份有限公司",
            "製造廠廠址": "桃園市楊梅區梅獅路二段629號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        }
    ],
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1012001600",
            "成分名稱": "OXALIPLATIN",
            "含量描述": "",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Eloxatin_box & vial-104-09-03(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024563&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "1. Eloxatin solution_TWPI_(CN)_GC update_2021.05.05_TFDA comments-clean-110-05-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024563&Seq=036&Type=9"
        },
        {
            "title": "Eloxatin 5 mg-Carton_533774-108-11-06(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024563&Seq=011&Type=8"
        },
        {
            "title": "Eloxatin solution sticker___20120817.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024563&Seq=010&Type=8"
        }
    ]
}